People: Becton Dickinson and Co (BDX)
8 Dec 2016
Mr. Vincent A. Forlenza is Chairman of the Board, President, Chief Executive Officer of the Company. He is a global medical technology company headquartered in Franklin Lakes, New Jersey. Mr. Forlenza joined BD in 1980 and has held leadership positions in the United States and Europe. These include appointments as Senior Vice President, Technology, Strategy and Development; President of BD Biosciences; and Executive Vice President and President, BD Diagnostics. Mr. Forlenza was named President in January 2009, assumed additional responsibility as Chief Operating Officer in July 2010, and became Chief Executive Officer in October 2011 and Chairman of the Board in July 2012. Mr. Forlenza is active in various professional and community associations. He is the current chairman of the Advanced Medical Technology Association (AdvaMed) Board of Directors. He has served on both the AdvaMed Board and its Executive Committee since 2010 and is the past chair of the association’s Board Committee on Technology and Regulation. In addition, he served as chairman of the Board for AdvaMedDx, a division of AdvaMed focused on the unique needs and issues facing diagnostics manufacturers. As AdvaMedDx chair, Forlenza oversaw significant growth of the division and helped establish AdvaMedDx as the leading advocate for the value of diagnostics. Mr. Forlenza currently serves on the Board of Trustees at The Valley Health Systems and previously served as Chairman of The Valley Hospital. He is a member of the Advisory Board for the P.C. Rossin College of Engineering and Applied Sciences at Lehigh University and is a member of the Board of Trustees at Lehigh. Mr. Forlenza obtained his bachelor’s degree in chemical engineering from Lehigh University in 1975 and his MBA from Wharton Graduate School, University of Pennsylvania in 1980.
|Total Annual Compensation, USD||2,707,080|
|Restricted Stock Awards, USD||8,958,120|
|Long-Term Incentive Plans, USD||--|
|All Other, USD||44,827|
|Fiscal Year Total, USD||11,710,000|